News - Page 19 - Psychedelic Alpha

Read more about the article A Discussion with Ernesto Londoño, Author of “Trippy: The Peril and Promise of Medicinal Psychedelics”

A Discussion with Ernesto Londoño, Author of “Trippy: The Peril and Promise of Medicinal Psychedelics”

Post published:February 1, 2024
Post category:Interviews

Read more about the article Interview: Compass Pathways CEO Kabir Nath Discusses Commercialisation, ‘Psychological Support’ and Competitive Landscape

Interview: Compass Pathways CEO Kabir Nath Discusses Commercialisation, ‘Psychological Support’ and Competitive Landscape

Post published:January 31, 2024
Post category:Interviews Pα+

Read more about the article Psychedelic Policy Reform & Legal Markets in 2023

Psychedelic Policy Reform & Legal Markets in 2023

Post published:January 30, 2024
Post category:2023 Year in Review Analysis

Read more about the article Colorado Department of Revenue Natural Medicine Division Listening Sessions: Round 2

Colorado Department of Revenue Natural Medicine Division Listening Sessions: Round 2

Post published:January 30, 2024
Post category:Colorado Natural Medicine Advisory Bulletin

Read more about the article Pα+ Psychedelic Bulletin #154: Public & Industry Respond to DEA’s Renewed DOI and DOC Scheduling Plan; TARA Mind Scores $8m Seed; Updates on State Psychedelics Programs

Pα+ Psychedelic Bulletin #154: Public & Industry Respond to DEA’s Renewed DOI and DOC Scheduling Plan; TARA Mind Scores $8m Seed; Updates on State Psychedelics Programs

Post published:January 26, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Ensuring the Affordable Becomes Accessible – Lessons from Ketamine’s Antidepressant Development and a Vision for More Equitable Drug Development

Ensuring the Affordable Becomes Accessible – Lessons from Ketamine’s Antidepressant Development and a Vision for More Equitable Drug Development

Post published:January 25, 2024
Post category:Analysis Opinions

Read more about the article European Union Grants €6.5M for Multi-Site Psilocybin Study in Palliative Patients

European Union Grants €6.5M for Multi-Site Psilocybin Study in Palliative Patients

Post published:January 24, 2024
Post category:Analysis News

Read more about the article Psychedelics M&A and Partnerships in 2023

Psychedelics M&A and Partnerships in 2023

Post published:January 22, 2024
Post category:2023 Year in Review Analysis

Read more about the article Psychedelic Funding & Public Markets in 2023

Psychedelic Funding & Public Markets in 2023

Post published:January 18, 2024
Post category:2023 Year in Review Analysis

Read more about the article Pα+: Knowledge Gaps in Psychedelic Medicalisation, According to ECNP and Regulators

Pα+: Knowledge Gaps in Psychedelic Medicalisation, According to ECNP and Regulators

Post published:January 17, 2024
Post category:Analysis Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.